Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Burcon Nutrascience, Enthusiast Gaming, EXMceuticals - Investing in the future

Innovative technologies and social trends often determine the positive performance of an investment portfolio. The biggest challenge, however, is to recognize the development of a new need in society at the right time and to benefit from it with the right companies. But unders...
Mario Hose | April 28, 2020 |

Coverage Initiated on 'Almost Famous' Energy Firm with Thermal Oil, Natural Gas Assets

Coverage Initiated on 'Almost Famous' Energy Firm with Thermal Oil, Natural Gas Assets Source: Streetwise Reports 04/18/2019 The reasons why this stock is attractive now are presented in a CIBC report. In an April 16 research note, analyst Trevor Bollan...
Streetwise Reports | April 23, 2019 |

Coverage Initiated on Biotech Whose Therapies 'Can Compete with CAR-Ts'

The reasons for the Buy rating on the U.K. firm are delineated in a ROTH Capital Partners report. In a May 30 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on Adaptimmune Therapeutics Plc (ADAP:NASDAQ) with a...
Streetwise Reports | June 10, 2019 |

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

Shares of Mallinckrodt Plc are trading more than 60% higher today on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. Global biopharmaceutical company Mallinckrodt Plc (MNK:NYSE) announced today that it has ent...
Streetwise Reports | September 11, 2019 |

US Indexes Continue to Rally Within A Defined Range

This week ended with the S&P, Dow Industrials and Nasdaq stalling near recent highs. From a technical perspective, both Thursday and Friday setup small range price bars (Doji candles or small Spinning Top type bars) after the upside price move on Wednesday. These are indicativ...
Chris Vermeulen | September 16, 2019 |

NexTech AR Solutions Update After Major Ramp-Up

Technical analyst Clive Maund provides an update on the prospects for this technology firm. While clivemaund.com is primarily a resource stocks website, we recognize that investing is an opportunity cost game, and for this reason we have no problem buying a tech stock...
Streetwise Reports | November 26, 2019 |

Best-of-Breed Hemp/CBD Producers

Hemp/CBD heats up. Wall Street catches on. Next wave begins: CVS Pharmacy and Walgreens sell CBD. The hemp/CBD phenomena grows. Investors appear to be catching on. Our universe of publicly traded CBD "pure-plays" suggests the two "best-of-breed." Charlotte'...
Streetwise Reports | April 3, 2019 |

Royalties Inc.: the most fun, most lucrative investment you know and love, but never had the opportu

Royalties Inc. focuses on cash flow generating royalty opportunities across a wide variety of very different industries. Through its stake in Music Royalties Inc., the Toronto-based company provides direct exposure to music revenues from the recent hyper-growth in glo...
Simon Druker | April 25, 2023 |

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. Just a few days after reporting third quarter 2019 earnings, late-stage biotechnology company Iovance Biothe...
Streetwise Reports | November 12, 2019 |

Is The Technology Sector Setting Up For A Crash? Part III

FANG stocks seem uniquely positioned for some extreme rotation over the next 6+ months. The continued capital shift that has taken place over the past 5+ years has driven investment and capital into the Technology sector – much like the DOT COM rally. The euphoric rally in t...
Chris Vermeulen | February 19, 2020 |
1 2 3 4 5 6 7 8 9 10 ...
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested